Cape Fear Biocapital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- HQ
- NC
Cape Fear BioCapital is an early-stage venture capital firm. It backs therapeutics companies that emerge from North Carolina's research ecosystem.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Pre-seed, Seed | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | NC | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Cape Fear BioCapital Fund I, LP Cape Fear BioCapital is an early-stage venture firm backing therapeutics companies emerging from North Carolina's research ecosystem. It writes first checks at pre-seed to seed, targeting companies within three years of an IND filing with differentiated biology. Inferred from the firm's website | 2024 | $8.99M to $9.5M (Form D) | Open, writing first checks |
03 · People across funds
No team members identified yet.
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026